Glutaredoxin-1 alleviates acetaminophen-induced liver injury by decreasing its toxic metabolites
Journal of Pharmaceutical Analysis · 2023-12 · 13 (12) · 1548-1561
DOI: 10.1016/j.jpha.2023.08.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2023-12. Verfasst von Ying Xu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Institute of Metabolic Diseases and Pharmacotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Foundation for Innovative Research Groups of the National Natural Science Foundation of China, National Natural Science Foundation of China, Central South University.
Abstract (Originalsprache)
Excessive N-acetyl-p-benzoquinone imine (NAPQI) formation is a starting event that triggers oxidative stress and subsequent hepatocyte necrosis in acetaminophen (APAP) overdose caused acute liver failure (ALF). S-glutathionylation is a reversible redox post-translational modification and a prospective mechanism of APAP hepatotoxicity. Glutaredoxin-1 (Glrx1), a glutathione-specific thioltransferase, is a primary enzyme to catalyze deglutathionylation. The objective of this study was to explored whether and how Glrx1 is associated with the development of ALF induced by APAP. The Glrx1 knockout mice (Glrx1-/-) and liver-specific overexpression of Glrx1 (AAV8-Glrx1) mice were produced and underwent APAP-induced ALF. Pirfenidone (PFD), a potential inducer of Glrx1, was administrated preceding APAP to assess its protective effects. Our results revealed that the hepatic total protein S-glutathionylation (PSSG) increased and the Glrx1 level reduced in mice after APAP toxicity. Glrx1-/- mice were more sensitive to APAP overdose, with higher oxidative stress and more toxic metabolites of APAP. This was attributed to Glrx1 deficiency increasing the total hepatic PSSG and the S-glutathionylation of cytochrome p450 3a11 (Cyp3a11), which likely increased the activity of Cyp3a11. Conversely, AAV8-Glrx1 mice were defended against liver damage caused by APAP overdose by inhibiting the S-glutathionylation and activity of Cyp3a11, which reduced the toxic metabolites of APAP and oxidative stress. PFD precede administration upregulated Glrx1 expression and alleviated APAP-induced ALF by decreasing oxidative stress. We have identified the function of Glrx1 mediated PSSG in liver injury caused by APAP overdose. Increasing Glrx1 expression may be investigated for the medical treatment of APAP-caused hepatic injury.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Institute of Metabolic Diseases and Pharmacotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
Förderung
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
- National Natural Science Foundation of China
- Central South University
- China Postdoctoral Science Foundation
- Sichuan University
- Xiangya Hospital, Central South University
Zitieren
APA
Xu, Y., Xia, Y., Liu, Q., Jing, X., Tang, Q., Zhang, J., Jia, Q., Zhang, Z., Li, J., Chen, J., Xiong, Y., Li, Y., & He, J. (2023). Glutaredoxin-1 alleviates acetaminophen-induced liver injury by decreasing its toxic metabolites. Journal of Pharmaceutical Analysis, 13(12), 1548-1561. https://doi.org/10.1016/j.jpha.2023.08.004
Vancouver
Xu Y, Xia Y, Liu Q, Jing X, Tang Q, Zhang J, et al. Glutaredoxin-1 alleviates acetaminophen-induced liver injury by decreasing its toxic metabolites. Journal of Pharmaceutical Analysis. 2023;13(12):1548-1561. doi:10.1016/j.jpha.2023.08.004
BibTeX
@article{Xu2023,
author = {Xu, Ying and Xia, Yan and Liu, Qinhui and Jing, Xiandan and Tang, Qin and Zhang, Jinhang and Jia, Qingyi and Zhang, Zijing and Li, Jiahui and Chen, Jiahao and Xiong, Yimin and Li, Yanping and He, Jinhan},
title = {Glutaredoxin-1 alleviates acetaminophen-induced liver injury by decreasing its toxic metabolites},
journal = {Journal of Pharmaceutical Analysis},
year = {2023},
volume = {13},
number = {12},
pages = {1548--1561},
doi = {10.1016/j.jpha.2023.08.004}
}
EUVIMED